Succinate-triggered SUCNR1 signaling affects cellular metabolism and has been documented in multiple pathological processes, including ischemia-reperfusion, renin-induced hypertension, cardiac hypertrophy, and diabetic nephropathy and inflammation (Gilissen et al., 2016; Lückmann et al., 2020). This evidence concerns the gene SUCNR1 and diabetic kidney disease.